جستجوی استاد راهنمای دانشگاهی

Per Bruheim is a Professor at the Department of Biotechnology and Food Science, Norwegian University of Science and Technology (NTNU). He leads the Bruheim research group, focusing on Deep Phenotyping of prokaryotic and eukaryotic systems using advanced metabolomics, fluxomics, and lipidomics techniques. He is the scientific leader of the NV faculty Mass Spectrometry lab and has developed targeted/non-targeted MS methods applied to diverse biological systems. Teaching roles include leading the 2-year and 5-year Biotechnology programs (MSBIOTECH and MBIOT5). He teaches courses such as TBT4140 Biochemical Engineering, TBT4110 Microbiology, and TKP4170 Process Design. Current research projects include targeting antibiotic resistance via bacterial stress responses (Trond Mohn Foundation), chemically defined cell culture media development, and peptide drug inhibition of translesion synthesis mechanisms. Research interests center on metabolomics and systems biology approaches to study microbial physiology and antibiotic resistance, with applications in bioprocessing and sustainable protein production. His lab employs mass spectrometry for precise metabolic profiling and collaborates internationally on projects involving lipidomics and flux analysis. Advising and grants involve mentoring over a dozen master’s theses on topics like microbial fermentation optimization, single-cell protein production, and recombinant protein expression. He actively pursues funding for projects addressing AMR mechanisms and bioprocess innovation. The Bruheim group also collaborates with industry on sustainable raw material utilization for microbial cultures. Labs/Teams: Leads the Mass Spectrometry facility at NTNU and directs the Bruheim research group within the Institute of Biotechnology (IBT). Collaborates with national/international partners in microbiology, metabolomics, and bioprocessing.

• Metabolomics
• Antibiotic Resistance
• Biotechnology
• +۵ مورد دیگر

Anton Baysa is a Senior Lecturer at the University of Oslo's Department of Pathology within the Faculty of Medicine. His research focuses on cardiovascular pathophysiology, particularly mechanisms of inflammation, mitochondrial dysfunction, and cellular repair following myocardial infarction and ischemia-reperfusion injury. He has published extensively on topics including Toll-like receptor signaling, mitochondrial DNA-induced inflammation, and the role of adaptor proteins in cardiac healing. His work integrates molecular biology, immunology, and clinical cardiology to understand and mitigate cardiac damage. Collaborative projects include studies on extracellular vesicles in surgery-related complications and growth factor pathways in myocardial repair. Key Research Themes: Cardiac inflammation mechanisms, mitochondrial damage responses, post-infarction healing, oxidative stress mitigation Recent Projects: Investigating p66ShcA protein signaling, nucleolin inhibition effects, and BMP-mediated cardiac remodeling

• Cardiology
• Molecular Biology
• Cardiovascular Pathology
• +۵ مورد دیگر

Lise-Lotte Gundersen is a Professor in the Department of Chemistry at the University of Oslo, where she leads the Section for Catalysis and Organic Chemistry. She has been a faculty member since 1996, becoming a full Professor in 2001. Her work bridges synthetic organic chemistry with medicinal applications, with particular focus on marine-derived compounds. Her educational background includes: Cand. pharm. (Ms. pharm.), Department of Pharmacy, University of Oslo, 1987 Dr. scient. (PhD), Department of Chemistry, University of Oslo, 1991 Post doc. (NATO Science Fellow), Yale University, 1992 Gundersen's research program centers on synthetic organic chemistry and medicinal chemistry, with special emphasis on marine natural products and antimicrobial agents. She develops innovative methodologies for synthesizing complex heterocyclic compounds, which have applications in drug discovery. Her work often bridges the gap between fundamental organic synthesis and biological applications, particularly in the areas of antibiotic development and marine pharmacology. Her publication record shows consistent productivity with over 30 publications since 2011, demonstrating expertise in heterocyclic chemistry, particularly with phenanthridines, purines, and marine natural product analogs. Her recent work has increasingly focused on marine-derived antimicrobial compounds and their synthetic analogs, reflecting her commitment to addressing antibiotic resistance through chemical synthesis. She has held numerous leadership positions including Head of the Organic Chemistry Section (2014-present) and has been actively involved in the academic community through membership on the international scientific committee for the European Symposia on Organic Chemistry (ESOC) and as Norwegian representative to EUCHEM's Organic Chemistry Division.

• Synthetic organic chemistry
• Medicinal chemistry
• Marine natural products
• +۴ مورد دیگر

Camilla Huse is a Research Fellow at the Research Institute for Internal Medicine, University of Oslo, affiliated with the Faculty of Medicine. Her work focuses on immune mechanisms in cardiovascular diseases and infectious disease pathophysiology, particularly in myocardial infarction and severe COVID-19. She investigates cytokine regulation, extracellular matrix remodeling, and inflammatory pathways in clinical settings. Her research group explores therapeutic targets in atherosclerosis and myocardial injury, with contributions to clinical trials like the ASSAIL-MI study evaluating IL-6 inhibition. She has published extensively on topics including neutrophil activity, circular RNA roles in heart attacks, and DNA repair mechanisms in viral infections.

• Cardiovascular Disease
• Immunology
• Infectious Diseases (COVID-19)
• +۳ مورد دیگر

Ines Heiland is a Professor at the Department of Biomedicine, Faculty of Medicine, University of Bergen. Her research integrates systems biology and computational modeling to investigate metabolic networks, with a focus on NAD and tryptophan metabolism, mitochondrial function, and circadian regulation. University: University of Bergen School: Faculty of Medicine Department: Department of Biomedicine Position: Professor Email: i.heiland@uib.no Her educational background is not explicitly detailed in the provided texts, but her extensive research and supervisory roles indicate a strong academic foundation in systems biology and molecular metabolism. Ines Heiland's research centers on understanding how metabolic networks regulate cellular health and disease. She employs computational models to study NAD homeostasis, tryptophan catabolism, and their roles in aging, cancer, and neurodegenerative conditions. Her work emphasizes the integration of multi-omics data and kinetic modeling to uncover regulatory mechanisms in metabolic pathways. The recent articles highlight a consistent focus on NAD metabolism, metabolic modeling, and the interplay between metabolism and epigenetics. Themes include the evolution of metabolic pathways, subcellular compartmentation of metabolites, and the development of bioinformatics tools for metabolic analysis. Her publications span from algorithm development (e.g., GEMCAT) to physiological insights in aging and disease. She has contributed to editorial and review work, such as the 2020 editorial on systems biology challenges and the 2015 review on NAD metabolism dynamics, underscoring her leadership in the field. Supervised PhD student: Mathias Bockwoldt Ines Heiland has been involved in collaborative research projects, often in partnership with institutions like UiT The Arctic University of Norway. She participates in networks such as NORBIS and BioCat, contributing to interdisciplinary efforts in biotechnology and systems biology. Her work involves both theoretical modeling and experimental validation, particularly in the context of marine biomass conversion and Arctic bioplastics.

• Systems Biology
• Metabolic Modeling
• NAD Metabolism
• +۷ مورد دیگر

Pierre Chymkowitch is an Associate Professor at the University of Oslo , affiliated with the Section for Biochemistry and Molecular Biology . His research focuses on the transcriptional and epigenetic regulation of cell fate and the dynamics of SUMOylation in chromatin remodeling during adipocyte differentiation . He employs advanced techniques such as ChIP-seq, RNA-seq, and confocal microscopy to study human and murine adipose stem cells, linking these mechanisms to obesity-related diseases like diabetes and cancer. Academic Rank: Associate Professor Institution: University of Oslo Section: Biochemistry and Molecular Biology Email: pierre.chymkowitch@ibv.uio.no Research Interests Transcriptional regulation in cellular differentiation SUMOylation-mediated chromatin dynamics Adipose tissue biology and obesity-related diseases Cell cycle and transcriptional homeostasis Epigenetic mechanisms in carcinogenesis Publication Trends Chymkowitch's recent work (2025) explores SUMOylation inhibition as a therapeutic target for metabolic disorders via TAK-981. Earlier studies (2023-2011) span mitotic chromatin resetting , Cdk1 regulation of transcription , and sumoylation in ribosomal gene expression , with a strong emphasis on interdisciplinary approaches bridging molecular biology and clinical applications. Laboratory & Team He leads the Chymkowitch group at the University of Oslo, collaborating on high-throughput genomic methods and classical biochemistry to unravel SUMOylation networks in developmental and disease contexts.

• Transcription
• Chromatin
• Cellular Differentiation
• +۵ مورد دیگر

Jan Oldenburg serves as Professor II in the Division of Medicine and Laboratory Sciences at the University of Oslo's Faculty of Medicine, based at Akershus University Hospital. His clinical and research activities focus on urologic malignancies with particular emphasis on testicular, prostate, and renal cancers. His research interests center on urologic oncology , specifically the management of testicular germ cell tumors, prostate cancer therapeutics, and renal cell carcinoma. Key areas include platinum-based chemotherapy toxicity, cancer survivorship issues, and the development of evidence-based clinical guidelines. His work frequently addresses long-term complications in cancer survivors such as neurotoxicity, ototoxicity, and endocrine dysfunction. His publication portfolio demonstrates consistent leadership in major international guideline initiatives, including the EAU-EANM-ESTRO-ESUR-ISUP-SIOG prostate cancer guidelines and ESMO-EURACAN testicular cancer guidelines. Recent work shows increasing focus on targeted therapies (PARP inhibitors), immunotherapy combinations, and real-world evidence in metastatic disease settings. As an active contributor to clinical guideline development, he participates in multiple European Association of Urology and ESMO consensus panels. His research utilizes Norwegian cancer registries and population-based cohorts to investigate survivorship issues and treatment outcomes. He maintains active clinical trial involvement, particularly in phase III studies evaluating novel combinations for metastatic prostate cancer (TALAPRO-2) and advanced urothelial carcinoma (CheckMate 901). His work bridges clinical practice with translational research through the Translational Cancer Research group at Akershus University Hospital.

• Urologic Oncology
• Testicular Cancer
• Prostate Cancer
• +۴ مورد دیگر

Coen Campsteijn is an Associate Professor at the University of Oslo's Faculty of Medicine, leading the Nuclear Envelope Dynamics Group. His research focuses on nuclear envelope architecture, cell division mechanisms, and genome stability. He holds a PhD from Radboud University (Netherlands) and has held postdoctoral positions at key institutions like the Stenmark Lab and Thompson Lab. His work spans ESCRT machinery function, micronuclei formation, and mitotic regulation. Notable projects include studies on abscission checkpoints and nuclear envelope sealing during cell division. Education: PhD in Molecular Biology, Radboud University (2005) Postdoctoral Research: SARS Centre (2006–2011), ICR (2011–2016) Research Interests: ESCRT complex dynamics in cytokinesis Mitotic fidelity and stress responses Nuclear lamina integrity and laminopathies Genome stability in cancer contexts Publications: Over 40 peer-reviewed articles in top journals like Nature , Nature Cell Biology , and EMBO Reports , focusing on cellular mechanisms regulating nuclear architecture and division processes. Labs/Teams: Leads the Nuclear Envelope Dynamics research group at the Institute for Molecular Biosciences (IMB), collaborating with global teams on ESCRT machinery and genome stability projects.

• Nuclear Envelope Architecture
• Cell Division
• Genome Stability
• +۳ مورد دیگر

Pål Falnes is a Professor at the University of Oslo , affiliated with the Department of Biochemistry and Molecular Biology . His research focuses on protein methylation, particularly in mitochondrial contexts and its implications for RNA/DNA repair mechanisms. Active in studying seven-β-strand (METTL) methyltransferases and their roles in lysine methylation. Investigates mitochondrial enzymatic activity , including ATP synthase and citrate synthase regulation. Research Interests : Dr. Falnes specializes in post-translational modifications , particularly lysine and histidine methylation. His work bridges protein-RNA interactions , translation dynamics , and mitochondrial metabolism , with recent studies on METTL family members like METTL13, METTL18, and FAM173B. Article Trends : Publications highlight METTL methyltransferases in human proteomics, mitochondrial respiration regulation, and DNA/RNA repair via AlkB proteins. Key themes include chronic pain mechanisms , ribosome biogenesis , and sequence-specific enzymatic methylation . Research Groups : He leads the Biological Methylation - Falnes group and contributes to the Center for Computational Inference in Evolutionary Life Science (CELS) .

• Biochemistry
• Molecular Biology
• Protein Methylation
• +۵ مورد دیگر

Eivind Valen is a Professor at the University of Oslo and holds multiple associate leadership roles at the Center for Molecular Medicine Norway (NCMM) , Center for Myeloid Blood Cancer (C-MYC) , Computational Biology Unit (CBU) , and Michael Sars Center . His research spans RNA biology, genome editing, and translation regulation. Research Focus: Investigates pervasive translation in non-coding regions, CRISPR applications, and RNA structure using nanopore sequencing. Key Tools: Developed CHOPCHOP platforms and ORFik for genome editing and translation analysis. Recent Article Trends: Emphasize ribosome profiling, poly(A) tail dynamics, and CRISPR precision. Awards: Includes ERC Consolidator Grant, EIC Pathfinder award, and KG Jebsen Center recognition. Collaborations: Engaged with institutions across Norway and Europe, including Technische Universität Dresden and EMBL nodes.

• Translation
• RNA biology
• Genome editing
• +۶ مورد دیگر

Henrik Peter Sahlin Pettersen is an Associate Professor at the Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU). His research focuses on molecular mechanisms of DNA repair, cancer biology, and applications of digital pathology. He is affiliated with the Molecular Biology research group (http://www.ntnu.no/dmf/ikm/molbiol) and the DNA Repair and Genome Stability group (http://www.ntnu.no/dmf/ikm/dna-r). His work spans interdisciplinary areas including: Genomic instability and mutagenesis in cancer Role of tumor-associated macrophages in meningiomas Development of AI-driven tools for histopathological analysis Quantitative immunohistochemistry methods Recent studies highlight contributions to: IBD treatment mechanisms using patient-derived colonoids Disease differentiation in inflammatory bowel diseases through T-cell analysis Automated breast cancer segmentation techniques He actively collaborates across disciplines, integrating molecular biology with computational pathology solutions. His presentations at international conferences reflect commitment to advancing translational research in oncology and digital diagnostics.

• Molecular Biology
• DNA Repair
• Genome Stability
• +۵ مورد دیگر

Hege Berg Henriksen is a Researcher at the University of Oslo's Department of Nutritional Sciences, Faculty of Medicine. Her work focuses on clinical nutrition, dietary interventions, and their impact on colorectal cancer patients, body composition analysis, and public health. She leads projects such as the CRC-NORDIET study on dietary guidelines for colorectal cancer survivors and the DIGIKOST study developing digital dietary assessment tools. She holds a PhD in Clinical Nutrition (2018) and a Cand. Scient. in Biology (1999). Key Research Projects: NUTRIOME: Precision nutrition and postprandial immune response Nutrifrail: Bone health in frail elderly Omega3PT: Omega-3 fatty acid effects on triglycerides LongITools: Life-course environmental and lifestyle exposome CRC-NORDIET: Diet and colorectal cancer survival Technical Expertise: Body composition analysis (DXA, bioimpedance), dietary assessment tools, clinical trial design.

• Clinical Nutrition
• Colorectal Cancer Research
• Body Composition Analysis
• +۳ مورد دیگر

Professor Christine Henriksen is affiliated with the University of Oslo (since 2024) and the Faculty of Medicine , where she leads clinical nutrition research. She has held previous roles at Bjørknes University College and Atlantis Medical College, and collaborates with Oslo University Hospital, Akershus University Hospital, and Norwegian Sports Academy. PhD in Clinical Nutrition (2007, University of Oslo) Basic pedagogical qualification (2012, Oslo and Akershus University College) Her research focuses on malnutrition in cancer patients , celiac disease and gluten intolerance , vitamin/mineral metabolism , and nutritional interventions for children . Google Scholar highlights 2025 articles on energy expenditure in bowel cancer and 2024 studies on gluten-free diet adherence. Recent publications examine plant-based diets in colorectal cancer recovery, low-carbohydrate diets for obesity, and micronutrient status in intestinal failure. She developed validation studies for nutritional tools like BIA and PG-SGA , and contributes to Nordic Nutrition Recommendations through scoping reviews on minerals. Henriksen teaches courses including ERN1010 Introduction to Clinical Nutrition and ERN4410 Master's course in clinical nutrition . Her work spans collaborations with hospitals and implementation studies on nutritional support systems like MyFood.

• Clinical Nutrition
• Malnutrition in Cancer Patients
• Celiac Disease and Gluten Intolerance
• +۵ مورد دیگر

Beate Vestad is a Postdoctoral Fellow at the Department of Transplantation Medicine , University of Oslo (UiO), with a focus on microbiome research and extracellular vesicle analysis in complex disease contexts. She actively contributes to the Genomics and Metagenomics in Inflammatory Disorders and Oslo HIV Research Network groups. Her research interests center on the intersection of gut microbiota alterations , systemic inflammation , and chronic disease progression in conditions like HIV , cardiovascular disorders , and post-COVID-19 complications . She explores how microbial metabolites (e.g., imidazole propionate, butyric acid) and vesicle-mediated signaling influence disease severity and patient outcomes. Her publications demonstrate expertise in multi-omics integration , EV isolation methodologies , and clinical microbiome studies , with collaborations across immunology , metabolic medicine , and cancer biology . Her work bridges fundamental microbiome science with translational clinical applications , particularly in high-risk patient populations .

• Gut Microbiome
• Cardiovascular Disease
• HIV
• +۶ مورد دیگر

Elin Moe serves as an Associate Professor II in Biomolecular and Structural Chemistry at the Department of Chemistry, UiT The Arctic University of Norway. Her research and teaching activities are centered around protein production technology and structural biology approaches to understanding DNA repair mechanisms. Dr. Moe's research focuses on the Base Excision Repair (BER) pathway in Deinococcus radiodurans , an extremophile bacterium renowned for its extraordinary resistance to ionizing radiation (tolerating doses up to 5,000 Grays without loss of viability, compared to 50 Grays for most organisms). Her work employs integrated structural biology methodologies to investigate how this organism repairs DNA damage. She has extensively studied various DNA repair enzymes including uracil-DNA glycosylase, endonuclease III, DNA ligase, and other components of the BER pathway in D. radiodurans . Additionally, her research extends to cold-adapted enzymes from marine organisms such as Atlantic cod and various Vibrio species, examining their structural adaptations to extreme environments. Her recent publications reveal a broadening research scope that now includes PARP1-related research with implications for cancer therapy, demonstrating the translational potential of her fundamental research on DNA repair mechanisms. The articles show a consistent pattern of structural and functional characterization of DNA repair proteins, with increasing applications in biomedical contexts. Dr. Moe teaches Kje-3603 Protein production technology and has collaborated extensively with researchers both within UiT and internationally. Her work bridges fundamental molecular biology with potential applications in radiation biology, extremophile adaptation, and cancer therapeutics.

• Structural Biology
• DNA Repair
• Base Excision Repair
• +۵ مورد دیگر